Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
International Clinical Trial Registry Platform (ICTRP)
A service set up by the World Health Organisation (WHO) to ensure that information regarding clinical trials is accessible to all those involved in healthcare decision making. The platform's aim is to improve research transparency and strengthen the validity and value of the scientific evidence base.
Clinical trials may also be referred to as interventional trials. Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioural treatments, process-of-care changes and preventive care.
WHO regards trial registration as the publication of an internationally-agreed set of information about the design, conduct and administration of clinical trials.
See also:
Clinical trial
Clinical trial enrolement
World Health Organisation (WHO)
Related terms
Food And Drug Administration (FDA), Lifestyle, Disease awareness marketing, Over the counter (OTC), Respondent, Cost-effective (healthcare economics), Pharmaceutical Pricing Regulation Scheme (PPRS), Investigational new drug (IND), e-Sampling, British Medical Association (BMA), Indication, Standard treatment, Prior approval, Phase I trials, Compliance,
Subscribe to our email news alerts
Featured jobs
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- Europe’s cancer community publishes new report on transforming patient care
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Eli Lilly announces $450m investment in US manufacturing site
- EU outlines measures to mitigate antibiotic shortage across Europe
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- JCVI recommends autumn COVID-19 vaccine booster for those at highest risk
- MIT researchers develop AI model to detect future lung cancer risk
- Merging global and local pharmacovigilance operations into a successful integrated approach
- Diversifying Healthcare AI with Federated Learning
- Alzheimer’s Society urges UK government to deliver on dementia plan
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Ipsen reports positive phase 3 data for Onivyde in pancreatic cancer
- World Health Organization releases latest set of COVID-19 guidelines
- Omnichannel communications in Medical Affairs: closing the gap between aspiration and reality
- Meeting healthcare’s rising challenges
PMHub
The Difference Collective
Welcome to the Difference Collective – a healthcare communications team of 80+ talented experts who Deliver Differently. We’re purpose-built around...
